CPHI Milan 2026
10/2026 – 10/2026
DERMAGO
441
14
6
4.8(8)
Proofs
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
暂无评论。
Dermago grants licensing rights for its self-developed generic approvals of Advantan/Skinatan and Skinoren/Beloren, as well as exclusive licensing rights for its patent-protected product Veregen.
留下您的评分和评论